Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, May 7th:
GenMark Diagnostics, Inc. : This molecular diagnostics company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 23.2% over the last 60 days.
GenMark Diagnostics Inc Price and Consensus
GenMark's shares gained more than 100% over the last one month compared to S&P 500’s rise of 8.3%. The company possesses a Momentum Score of A.
GenMark Diagnostics Inc Price
MarketAxess Holdings Inc. (MKTX - Free Report) : This operator of an electronic trading platform has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 13.9% over the last 60 days.
MarketAxess Holdings Inc Price and Consensus
MarketAxess’ shares gained more than 21.5% over the last one month. The company possesses a Momentum Score of B.
MarketAxess Holdings Inc Price
The Clorox Company (CLX - Free Report) : This manufacturer and marketer of consumer and professional products has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 9.5% over the last 60 days.
The Clorox Company Price and Consensus
Clorox’s shares gained 11.7% over the last one month. The company possesses a Momentum Score of B.
The Clorox Company Price
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
5 Stocks Set to Double
Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, May 7th:
GenMark Diagnostics, Inc. : This molecular diagnostics company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 23.2% over the last 60 days.
GenMark Diagnostics Inc Price and Consensus
GenMark's shares gained more than 100% over the last one month compared to S&P 500’s rise of 8.3%. The company possesses a Momentum Score of A.
GenMark Diagnostics Inc Price
MarketAxess Holdings Inc. (MKTX - Free Report) : This operator of an electronic trading platform has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 13.9% over the last 60 days.
MarketAxess Holdings Inc Price and Consensus
MarketAxess’ shares gained more than 21.5% over the last one month. The company possesses a Momentum Score of B.
MarketAxess Holdings Inc Price
The Clorox Company (CLX - Free Report) : This manufacturer and marketer of consumer and professional products has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 9.5% over the last 60 days.
The Clorox Company Price and Consensus
Clorox’s shares gained 11.7% over the last one month. The company possesses a Momentum Score of B.
The Clorox Company Price
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
5 Stocks Set to Double
Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on CLX - FREE
Get the latest research report on MKTX - FREE